Insurance Companies
Evaluate preventive screening ROI and risk stratification models. Reduce expensive cardiac interventions through early detection. Design structured care programs aligned with claims data. Co-develop cost-benefit analysis for wearable-based prevention.
Collaboration
Reduce Long-Term Costs Through Preventive Cardiovascular Care
CedarHeart offers insurance providers a strategic opportunity to improve member health while reducing claims costs. Research demonstrates that preventive CVD programs reduce hospitalizations by 17-51%, decrease emergency department visits, and lower overall healthcare expenditure.
- Premium Reduction Programs: Offer 10-20% premium discounts to policyholders who participate in regular CedarHeart monitoring and achieve health targets
- Eliminated Copayments: Remove cost-sharing for CVD screening, essential preventive medications (statins, antihypertensives), and monitoring devices
- Financial Incentive Programs: Provide monetary rewards ($5-$50) for completing educational modules, attending screenings, and achieving clinical milestones
- Wellness Integration: Incorporate CedarHeart monitoring into existing wellness programs with tiered benefits
- Access aggregate (de-identified) data on population health trends
- Identify high-risk members early for intensive case management
- Track effectiveness of preventive interventions on claims reduction
- Develop actuarial models for premium pricing based on participation
- Create specialized insurance products for participants (lower premiums, enhanced benefits)
- Develop family plans incorporating multi-generational CVD prevention
- Offer short-term policies covering young adults with genetic CVD risk factors
- Design products specifically for rural and underserved populations
- Collaborate on policy proposals for government subsidies of preventive care
- Advocate for national digital health standards
- Support healthcare system reforms emphasizing primary prevention
- Demonstrate cost-effectiveness to other insurers and government entities
Studies show CVD prevention programs yield return-on-investment within 2-3 years through reduced hospitalizations, decreased acute interventions, and improved chronic disease management. Early detection of atrial fibrillation alone reduces stroke incidence by 35%, with associated hospital cost savings exceeding program costs.
Insurance partners can participate as pilot funders (covering devices for a defined population), data analytics collaborators, or strategic investors in platform development. All partnerships include regular reporting on health outcomes and cost impacts.